{"version":"1.0","type":"link","title":"A phase II study of docetaxel and pembrolizumab plus Interleukin-12 gene therapy in non-metastatic, anthracycline-refractory triple negative breast cancer (INTEGRAL).","author_name":"Niravath P 외","author_url":"https://prs-insight.online/author/Niravath%20P","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/85774","thumbnail_width":1200,"thumbnail_height":630}